|
| 37482512 | Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. | Eur Urol | 2023 |
| 37678927 | Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis. | J Nucl Med | 2023 |
| 37779132 | Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study. | Eur J Hybrid Imaging | 2023 |
| 36759200 | [68]Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. | J Nucl Med | 2023 |
| 36635088 | Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer. | J Nucl Med | 2023 |
| 34326126 | A Comprehensive Assessment of <sup>68</sup>Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients. | J Nucl Med | 2022 |
| 34049987 | Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality? | J Nucl Med | 2022 |
| 33602654 | Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. | Eur Urol Oncol | 2022 |
| 32914197 | Effect of phase of enhancement on texture analysis in renal masses evaluated with non-contrast-enhanced, corticomedullary, and nephrographic phase-enhanced CT images. | Eur Radiol | 2021 |
| 34016732 | Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort. | J Nucl Med | 2021 |
| 34272322 | Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312). | J Nucl Med | 2021 |
| 33509974 | The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study. | J Nucl Med | 2021 |
| 31501965 | Update on MR Imaging of cystic retroperitoneal masses. | Abdominal Radiology | 2020 |
| 32627049 | Importance of phase enhancement for machine learning classification of solid renal masses using texture analysis features at multi-phasic CT. | Abdom Radiol (NY) | 2020 |
| 31375469 | <sup>18</sup>F-fluciclovine PET-CT and <sup>68</sup>Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. | Lancet Oncol | 2019 |
| 22485176 | Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury. | PLoS ONE | 2012 |
| 21296893 | Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome. | American Journal of Physiology - Lung Cellular and Molecular Physiology | 2011 |
| 21205799 | Sugar-free frosting, a homolog of SAD kinase, drives neural-specific glycan expression in the Drosophila embryo. | Development (Cambridge) | 2011 |
| 20688784 | Neural-specific α3-fucosylation of N-linked glycans in the Drosophila embryo requires fucosyltransferase A and influences developmental signaling associated with O-glycosylation. | Glycobiology | 2010 |
| 18725413 | The diversity of O-linked glycans expressed during Drosophila melanogaster development reflects stage- and tissue-specific requirements for cell signaling. | Journal of Biological Chemistry | 2008 |
| 14525722 | Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. | American Journal of Physiology - Regulatory Integrative and Comparative Physiology | 2004 |
| 15347725 | A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. | Journal of Nuclear Medicine | 2004 |
| 15212714 | Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. | Hum Gene Ther | 2004 |
| 14538050 | Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. | Molecular Imaging and Biology | 2002 |
| 12457279 | Monitoring adenoviral DNA delivery, using a mutant herpes simplex virus type 1 thymidine kinase gene as a PET reporter gene. | Gene Therapy | 2002 |
| 12086852 | Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene. | Cancer Cell | 2002 |
| 11867752 | Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. | Proceedings of the National Academy of Sciences of the United States of America | 2002 |
| 11197989 | 8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. | Journal of Nuclear Medicine | 2001 |
| 11704818 | Quantitative imaging of gene induction in living animals. | Gene Therapy | 2001 |
| 10880576 | High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. | Proceedings of the National Academy of Sciences of the United States of America | 2000 |
| 11021693 | Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET. | IEEE Trans Med Imaging | 2000 |
| 10051642 | Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. | Proc Natl Acad Sci U S A | 1999 |